Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 53.400 | 20140606, Panzner P
| 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 749 | 70.100 | | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 4.580 | 20120528, Patelis A
| 3.2.1 - Source Sensitized (IgE) | 2000 | Not Defined | IgE | 306 | 55.600 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 91.200 | 20141003, Beitia JM
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 101 | 92.080 | 20140306, Darsow U
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 54.550 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 23.960 | 20120528, Patelis A
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 13.950 | 20101214, Gadisseur R
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | IgE | 82 | 85.360 | 20080314, Westritschnig K
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | SPT | 82 | 67.070 | 20080314, Westritschnig K
| 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Italy | IgE | 77 | 88.300 | | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 26.300 | 20131020, van Rhijn BD
| 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 16.400 | 20140625, Armentia A
| 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 57 | 75.000 | | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 48.100 | 20120310, Twaroch TE
| 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 42.000 | 20140625, Armentia A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 63.000 | 20131014, Bokanovic D
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 22.000 | 20131014, Bokanovic D
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 43 | 79.100 | 20110713, Cabrera-Freitag P
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | France | IgE | 38 | 58.000 | | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 40.540 | 20090826, Ebo DG
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 49.000 | 20140127, Konradsen JR
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 54.280 | 20130605, Simon D
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Sweden | IgE | 35 | 51.000 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Austria | IgE | 29 | 45.000 | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 36.000 | 20140127, Konradsen JR
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 7.410 | 20110223, De Knop KJ
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 7.690 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 38.500 | 20120310, Twaroch TE
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Denmark | IgE | 26 | 58.000 | | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 12.000 | 20140821, Choi JS
| 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 25 | 84.000 | | 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 25 | 92.000 | | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 18.180 | 20091121, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 45.000 | 20091005, Ott H
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 95.000 | 20091121, Ebo DG
| 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Japan | IgE | 20 | 20.000 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Switzerland | IgE | 20 | 45.000 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Canada | IgE | 15 | 20.000 | | 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 12 | 68.000 | |
|